<DOC>
	<DOCNO>NCT01376674</DOCNO>
	<brief_summary>Immunological effect radiotherapy describe , evaluate time-dependant manner . In order identify possible time frame combination therapy , white blood cell isolate sample take different time point standard radiotherapy patient localised prostate cancer . The overall activity T-cell-system well tumor-specific T-cell-response evaluate .</brief_summary>
	<brief_title>T-cell-immunity During Standard Radiotherapy Localised Prostate Cancer</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Localised prostate cancer ( node negative ) definitive radiotherapy inform consent medication include steroid immunosuppressant</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>localise</keyword>
	<keyword>prostate cancer</keyword>
	<keyword>radiotherapy</keyword>
	<keyword>immunology</keyword>
</DOC>